The Federal Trade Commission said Friday that it is suing three drug middlemen, accusing them of inflating insulin prices.

The Federal Trade Commission took action Friday against the three largest pharmacy benefit managers, accusing the companies ...

The three price benefit managers jointly administer 80% of all prescriptions in the U.S., the FTC said in the lawsuit.

On Friday, the Federal Trade Commission (FTC) filed a formal complaint against three major pharmacy benefit managers ...

The federal government is suing some pharmacy benefit managers over a system of drug rebates that regulators say has made the ...

Three companies that process about 80% of prescriptions in the United States — Caremark, Express Scripts and OptumRx — have ...

The Federal Trade Commission said pharmacy benefit managers created a "perverse drug rebate system" that artificially ...

FTC Sues Prescription Drug Middlemen for Artificially Inflating Insulin Drug Prices – Includes Caremark, Express Scripts, ...

The federal government has initiated a lawsuit against leading Pharmacy Benefit Managers (PBMs) — Caremark, Express Scripts, and OptumRx — accusing them of anticompetitive practices that have driven ...

“We are able to purchase drugs on a federal pricing program called 340 B. Starting in July, we noticed a dramatic increase in our insulin costs." A disproportionate share hospital treats a ...

SAN DIEGO, September 19, 2024--(BUSINESS WIRE)--Tandem Diabetes Care, Inc. (NASDAQ: TNDM), a leading insulin delivery and diabetes technology company, today announced that its t:slim X2 insulin ...